by 社團法人台灣肝癌醫學會
<p>《肝膽相照：肝癌專家說》 <br /> <br />此節目由社團法人台灣肝癌醫學會官方製作的節目 《肝膽相照》由一群肝癌專科醫師為您解答》我們致力於透過專業且正確的衛教資訊，縮短醫病之間的認知落差，減少醫療糾紛，並在治療過程中，為醫病雙方注入更多的溫暖與信任。我們將邀請全台肝癌領域的權威專家，為您解析最新的國際治療指引，與您攜手面對肝癌的挑戰。讓專家陪您一起走過這段路程，尋求最好的治療選擇。 <br /> <br />節目結尾 <br /> <br />台灣肝癌醫學會了解，許多病友在面對肝癌時，可能感到無助、徬徨，甚至因資訊的缺乏而感到絕望。我們以中立且專業的立場，為您帶來最正確的醫學新知，希望透過 《肝膽相照》，能為您帶來一絲溫暖與希望。我們相信，只要與疾病共存，依然可以擁有快樂、健康的生活。感謝您的收聽，我們期待與您再次相見。 <br /> <br /> <br/>Powered by <a href="https://firstory.me/zh">Firstory Hosting</a></p>
Language
🇨🇳
Publishing Since
12/3/2024
Email Addresses
1 available
Phone Numbers
0 available
December 10, 2024
肝癌專家黃怡翔介紹最新的7-11準則，如何改變中期肝癌治療策略，提升治癒率和為晚期患者帶來治療希望和可能性。
December 3, 2024
Taiwan liver cancer experts Dr. Huang Yi-xiang and Dr. Chi Chen-da share in-depth insights on liver cancer causes, diagnosis, and treatment options, empowering listeners with expert knowledge.
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.